ÂÜÀòÂÒÂ×

Stefan Beyer has built a distinguished career in the manufacturing of human vaccines and biologics, emphasizing compliance with cGMP standards. Previously, they served as Manager of Business Development at Scil Proteins and as Director of Corporate and Business Development at BioProtect Research. Currently, Stefan is the Chairperson of the Board of Directors at VIVEbiotech and serves as an Executive Advisor at Ampersand Capital Partners, while also working as a strategy advisor in various freelance roles. Their leadership experience also includes a recent position as President and Managing Director at Vibalogics from 2020 to 2023.